Metropolitan Life Insurance CO Viking Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

  • $253 Million
  • Q2 2024

Shares

47 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$17.4 - $94.5 $3,062 - $16,632
-176 Reduced 3.17%
5,377 $440,000
Q3 2023

Nov 14, 2023
BUY
$10.92 - $16.0 $3,265 - $4,784
299 Added 5.69%
5,553 $61,000
Q2 2023

Aug 10, 2023
BUY
$14.84 - $24.79 $77,969 - $130,246
5,254 New
5,254 $85,000
Q2 2022

Aug 11, 2022
SELL
$2.11 - $3.15 $10,037 - $14,984
-4,757 Closed
0 $0
Q1 2022

Jun 20, 2023
BUY
$3.0 - $4.88 $14,271 - $23,214
4,757 New
4,757 $14,000
Q1 2022

Mar 30, 2023
SELL
$3.0 - $4.88 $31,626 - $51,444
-10,542 Reduced 68.91%
4,757 $14,000
Q1 2022

May 12, 2022
SELL
$3.0 - $4.88 $31,626 - $51,444
-10,542 Reduced 68.91%
4,757 $14,000
Q4 2021

Jun 21, 2023
BUY
$4.6 - $6.72 $70,375 - $102,809
15,299 New
15,299 $70,000
Q4 2021

Mar 30, 2023
SELL
$4.6 - $6.72 $12,787 - $18,681
-2,780 Reduced 15.38%
15,299 $70,000
Q4 2021

Feb 15, 2022
SELL
$4.6 - $6.72 $12,787 - $18,681
-2,780 Reduced 15.38%
15,299 $70,000
Q3 2021

Jun 21, 2023
BUY
$5.58 - $7.04 $100,880 - $127,276
18,079 New
18,079 $113,000
Q3 2021

Mar 30, 2023
BUY
$5.58 - $7.04 $47,541 - $59,980
8,520 Added 89.13%
18,079 $113,000
Q3 2021

Nov 15, 2021
BUY
$5.58 - $7.04 $47,541 - $59,980
8,520 Added 89.13%
18,079 $114,000
Q2 2021

Jun 21, 2023
BUY
$5.19 - $6.73 $49,611 - $64,332
9,559 New
9,559 $57,000
Q2 2021

Mar 30, 2023
SELL
$5.19 - $6.73 $56,519 - $73,289
-10,890 Reduced 53.25%
9,559 $57,000
Q2 2021

Aug 16, 2021
BUY
$5.19 - $6.73 $49,507 - $64,197
9,539 Added 47695.0%
9,559 $57,000
Q1 2021

Jun 26, 2023
BUY
$5.74 - $9.67 $117,377 - $197,741
20,449 New
20,449 $129 Million
Q1 2021

Mar 30, 2023
BUY
$5.74 - $9.67 $65,171 - $109,793
11,354 Added 124.84%
20,449 $129,000
Q1 2021

May 14, 2021
SELL
$5.74 - $9.67 $52,090 - $87,755
-9,075 Reduced 99.78%
20 $129,000
Q4 2020

Jun 22, 2023
BUY
$5.3 - $6.71 $48,203 - $61,027
9,095 New
9,095 $51,000
Q4 2020

Mar 30, 2023
SELL
$5.3 - $6.71 $27,416 - $34,710
-5,173 Reduced 36.26%
9,095 $51,000
Q4 2020

Feb 16, 2021
SELL
$5.3 - $6.71 $27,416 - $34,710
-5,173 Reduced 36.26%
9,095 $51,000
Q3 2020

Jun 26, 2023
BUY
$5.73 - $8.11 $81,755 - $115,713
14,268 New
14,268 $83,000
Q3 2020

Mar 30, 2023
SELL
$5.73 - $8.11 $42,453 - $60,086
-7,409 Reduced 34.18%
14,268 $83,000
Q3 2020

Nov 13, 2020
SELL
$5.73 - $8.11 $42,453 - $60,086
-7,409 Reduced 34.18%
14,268 $83,000
Q2 2020

Jun 26, 2023
BUY
$4.35 - $8.08 $94,294 - $175,150
21,677 New
21,677 $156,000
Q2 2020

Mar 30, 2023
SELL
$4.35 - $8.08 $348 - $646
-80 Reduced 0.37%
21,677 $156,000
Q2 2020

Aug 14, 2020
SELL
$4.35 - $8.08 $348 - $646
-80 Reduced 0.37%
21,677 $156,000
Q1 2020

Jul 12, 2023
BUY
$3.45 - $7.95 $75,061 - $172,968
21,757 New
21,757 $101,000
Q1 2020

Mar 30, 2023
BUY
$3.45 - $7.95 $3,822 - $8,808
1,108 Added 5.37%
21,757 $101,000
Q1 2020

May 15, 2020
BUY
$3.45 - $7.95 $3,822 - $8,808
1,108 Added 5.37%
21,757 $102,000
Q4 2019

Jul 12, 2023
BUY
$6.38 - $8.73 $131,740 - $180,265
20,649 New
20,649 $165,000
Q4 2019

Mar 30, 2023
SELL
$6.38 - $8.73 $3,234 - $4,426
-507 Reduced 2.4%
20,649 $165,000
Q4 2019

Feb 14, 2020
SELL
$6.38 - $8.73 $3,234 - $4,426
-507 Reduced 2.4%
20,649 $166,000
Q3 2019

Jul 12, 2023
BUY
$6.55 - $8.6 $138,571 - $181,941
21,156 New
21,156 $145,000
Q3 2019

Mar 30, 2023
BUY
$6.55 - $8.6 $6,733 - $8,840
1,028 Added 5.11%
21,156 $145,000
Q3 2019

Nov 14, 2019
BUY
$6.55 - $8.6 $6,733 - $8,840
1,028 Added 5.11%
21,156 $146,000
Q2 2019

Jul 12, 2023
BUY
$7.67 - $10.63 $162,266 - $224,888
21,156 New
21,156 $175,000
Q1 2019

Jul 13, 2023
BUY
$7.58 - $9.94 $152,570 - $200,072
20,128 New
20,128 $200,000
Q1 2019

Mar 30, 2023
BUY
$7.58 - $9.94 $152,570 - $200,072
20,128 New
20,128 $200,000
Q1 2019

May 16, 2019
BUY
$7.58 - $9.94 $71,070 - $93,197
9,376 Added 87.2%
20,128 $200,000
Q1 2019

May 15, 2019
SELL
$7.58 - $9.94 $84,668 - $111,029
-11,170 Reduced 50.95%
10,752 $98,000
Q4 2018

Jul 13, 2023
BUY
$7.16 - $16.21 $156,961 - $355,355
21,922 New
21,922 $167,000
Q4 2018

Feb 14, 2019
BUY
$7.16 - $16.21 $132,932 - $300,954
18,566 Added 553.22%
21,922 $168,000
Q3 2018

Jul 13, 2023
BUY
$9.7 - $19.65 $148,633 - $301,096
15,323 New
15,323 $267 Million
Q3 2018

Nov 14, 2018
SELL
$9.7 - $19.65 $116,079 - $235,151
-11,967 Reduced 78.1%
3,356 $58,000
Q2 2018

Aug 15, 2018
BUY
$3.88 - $12.74 $59,453 - $195,215
15,323 New
15,323 $0

Others Institutions Holding VKTX

# of Institutions
466
Shares Held
65.9M
Call Options Held
6.24M
Put Options Held
2.97M
View Full List

About Viking Therapeutics, Inc.

VKTX Quotes by TradingView
  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $5.59B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email